International Review of Movement Disorders – serie

Autonomic dysfunction is one of the most prevalent non-motor symptoms that occurs in Parkinson's disease. Autonomic Dysfunction in Parkinson's Disease provides up to date information on this important topic, which affects quality of life of these patients. This include a large number of domains: orthostatic hypotension, excessive sweating, dry eyes, constipation, weight loss, increased sensitivity to heat and cold, sexual dysfunction.

Provides comprehensive reviews on different topics of autonomic dysfunction in Parkinson's disease Each chapter covers a specific autonomic symptom: classification, assessment, treatment Presents the newest information on each autonomic symptom in Parkinson's disease

Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson's Disease explores the results of numerous studies surrounding� in vitro and animal model evidence that looks at the impact of ?-synucleinopathy on neuronal dysfunction and behavioral impairments, (ii) how research in animal models supports the development of therapeutic strategies, and (iii) how findings in animal models might relate to the disease process in humans. In this book, the author's shed light upon the complex scenario of the mechanisms of cell death and approaches to neuroprotection/disease modification in PD, both in vitro to in vivo.

Along with degeneration, the pathological hallmark of PD is the presence of intraneuronal proteinaceous cytoplasmic inclusions, named Lewy Bodies (LB) that invade the whole nervous system as the disease progresses. Several fundamental discoveries have shed light upon the implication of the ?-syn protein in the pathogenesis of familial and sporadic forms of PD. Other proteins also accumulate in LB, but ?-syn is a major protein component of the pathological landmarks.

Updates on the latest research surrounding Mechanisms of Cell Death in Parkinson's Disease Includes In vitro and In vivo models of synucleinopathy Presents therapeutic strategies in Parkinson's Disease

The Neurobiology of the Gilles de la Tourette Syndrome and Chronic Tics, Volume Three reviews historical background and current nosology and guidelines. In addition, it includes an overview of pathophysiology, ranging from its genetic basis and changes in neurochemistry and electrophysiology to widespread neural circuits. Specific chapters cover Tourette syndrome from phenomenology and natural history to neurobiology, Update and Recent progress in the Neurobiology of Tourette Syndrome, Current guidelines and nosology of Tourette syndrome, Neuroimaging applications in Tourette's Syndrome, Clinical and neurodevelopmental brain imaging of Tourette syndrome, Altered Structural Connectivity in Gilles de la Tourette Syndrome, and much more.

The last 20?years have seen an exponential growing body of research dedicated to Gilles de la Tourette Syndrome in the understanding of the syndrome's complex genetics and underlying neurobiology. This unprecedented surge in basic and clinical research has resulted in over 3,000 scientific publications.

Examines Gilles de la Tourette Syndrome at behavioral, cognitive, clinical, electrophysiological, molecular and genetic levels Provides a comprehensive overview of the neurobiological aspects of Gilles de la Tourette Syndrome Edited and authored by top researchers and clinicians treating the Gilles de la Tourette Syndrome

The Neurobiology of the Gilles de la Tourette Syndrome and Chronic Tics, Part B, Volume Four reviews historical background, current nosology and guidelines. In addition, it includes an overview of pathophysiology, ranging from its genetic basis and changes in neurochemistry and electrophysiology to widespread neural circuits. Specific chapters cover The genetic basis of Gilles de la Tourette Syndrome, Genome-wide association study of Tourette Syndrome, De Novo mutations in Tourette Syndrome, Animal models for Tourette Syndrome, The neural-immune crosstalk in Tourette syndrome: from immunobiology to epistemology, Functional connectivity in the Gilles de la Tourette Syndrome, and much more. Includes examines of Gilles de la Tourette Syndrome at behavioral, cognitive, clinical, electrophysiological, molecular and genetic levels Provides a comprehensive overview of the neurobiological aspects of Gilles de la Tourette Syndrome Edited and authored by top researchers and clinicians treating Gilles de la Tourette Syndrome

International Review of Movement Disorders series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.

Provides the authority and expertise of leading contributors from an international board of authorsPresents the latest release in the International Review of Movement Disorders seriesUpdated release includes the latest information on Myoclonus

Digital Technologies in Movement Disorders, Volume Five updates on the latest advances in new technologies for the care of common conditions, including Parkinson's disease and other diseases. The book has been organized in four differentiated sections with chapters that cover an Introduction, key concepts, and overview of digital solutions, Applications of AI in MD, Digital Biomarkers in MD, Sensors basic concepts for the MD specialist, Wearable systems in MD, Quantitative gait analysis, The challenges and opportunities of remote evaluation in MD, Telemedicine in MD, ePROs, eCOA and other digital health solutions, HIFU, and other therapeutical applications of technology, and more.Includes a multidisciplinary review of topics such as the input of care providers and engineersReviews new technological advancesIncludes practice oriented technologies and innovations that have direct applications in the clinic

Movement Disorders Emergencies, Volume Six in the International Review of Movement Disorders series, highlights new advances in the field, with this new volume presenting interesting chapters that discuss Management of non-motor emergencies in Parkinson's disease, Movement disorders emergencies in metabolic diseases, Acute psychiatric problems in movement disorders, Emergencies in deep brain stimulation, Emergencies in pump therapies, Acute parkinsonism: from viruses to strange pathogens, Acute dystonia and status dystonicus dystonia, Emergencies in tic and choreic disorders, Telemedicine and digital health solutions for managing movement disorders emergencies, and much more.

Provides the authority and expertise of leading contributors from an international board of authorsPresents the latest release in the International Review of Movement Disorders seriesIncludes the latest information on Movement Disorders Emergencies

Device-Aided Therapies in Parkinson's Disease discusses the latest options from a global set of key opinion leaders and emerging specialists using a gender balanced modern and nuanced approach. Sample chapters cover The concept of continuous dopaminergic stimulation, Apomorphine Infusion, LCIG, LECIG, Foslevodopa/Foscarbidopa, ND0612, STN-DBS, Pallidal DBS, MRgFUS, Vestibular Neurostimulation, Patient selection and choice of therapy, The future: Stem cells? Gene therapy?, The future: Trophic factors, and Devices and the dashboard for PD.Provides the latest information on subcutaneous device based therapiesIncludes coverage on jejunal device based therapiesPresents information on additional surgical device based therapies

The book is organized into sections/chapters. Section I, The Renin-Angiotensin-Aldosterone System (RAAS) in health and disease, conveys topics like an overview and history of RAAS discovery and its significance in cardiovascular physiology, the RAAS in the cardiovascular system, including the cardiorenal axis, and other RAAS endocrine systems (in the liver, lungs, adrenal glands, and testes). RAAS pathways and second messengers (Cyclic AMP, Calcium), and receptors [AT1R, AT2R, MasR binding to the vasodilator angiotensin-(1-7)], medications targeting the RAAS, and effects of the RAAS on inflammation. Oxidative stress, vascular smooth muscle contraction, endothelial dysfunction, fibrosis, and the hypertrophic, anti-apoptotic, and pro-mitogenic effects of Angiotensin II. RAAS local brain systems and pleiotropic effects, including neuroinflammation, autophagy, endoplasmic reticulum stress, and mitochondrial dysfunction. Section II, the Renin-Angiotensin System (RAS) in Parkinson’s disease, deals with general considerations, pathogeny and pharmacotherapeutics, the RAS and Alzheimer’s disease and other neurodegenerative diseases, neuroprotective and anti-inflammatory properties of AT2 in motor neuron disease treatment, Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA); RAS modulation of dopaminergic neurotransmission: effects on Parkinson’s disease motor symptoms, motor fluctuations, memory, cognition and mood; ACEIs and ARBs’ therapeutic benefits on mood and depressive symptoms; brain RAS as a potential therapeutic target in psychiatric disorders; the risk of Parkinson’s disease and the use of Renin-angiotensin modulators; brain RAS regulation of stress and neuroinflammation, and participation of the hypothalamic-pituitary-adrenal axis; risk of Parkinson’s disease and the use of RAS modulators; the relationship between RAS, COVID-19, and Parkinson’s disease; RAS, Parkinson, and COVID-19: ACE2 and post COVID-19 parkinsonism; the relationship between RAS and other pathological conditions that increase PD risk. RAS role in the pathophysiology of diabetes and complications - nephropathy and retinopathy; gut microbiota and local gastrointestinal RAS two-way interaction; gut dysbiosis and impaired renin-angiotensin system (RAS) function in cognitive decline and neurodegeneration; gut microbiota impact on RAS-related disorders; gastrointestinal dopaminergic and renin-angiotensin systems; gut ACE2, probiotics supplementation, and diabetic retinopathy in type 1 diabetes; Ang-(1-7) protection in diabetes and diabetic retinopathy; ACE2 gene therapy improvement of glycemic control in diabetic mice.The Renin-Angiotensin-Aldosterone System (RAS) in health and disease.RAS pathways and second messengers (Cyclic AMP, Calcium), and receptors [AT1R, AT2R, MasR binding to the vasodilator angiotensin-(1-7)], medications targeting the RAS.Brain RAS and other local RAS pathways. Neurodegenerative disorders. Gut microbiota and local gastrointestinal RAS two-way interaction; gut dysbiosis and impaired renin-angiotensin system (RAS) function in cognitive decline and neurodegeneration.

Effects of Climate Change in Movement Disorders, Volume 10 in the International Review of Movement Disorders series, highlights new advances in the field, with this updated volume presenting interesting chapters on a variety of timely topics, including Climate Change and the Global Burden of Parkinson’s Disease and Movement Disorders, Air Pollution and Neurotoxicity: The Role of Environmental Pollutants in Movement Disorders, Extreme Heat, Sleep Disruption, and the Glymphatic System: Implications for Parkinson’s Disease, Climate-Driven Changes in Vector-Borne Diseases and Neuroinfections: Risks for Movement Disorders, The Impact of Climate Change on Food Security and Nutritional Deficiencies in Movement Disorders, and much more.Other sections cover Invisible Invaders: The Emerging Threat of Microplastics to Brain Health and Movement Disorders, Socioeconomic and Healthcare Disparities in Climate-Related Vulnerability for Parkinson's Disease and Movement Disorders, The Role of Heat Stress, Oxidative Damage, and Neuroinflammation in Parkinson’s disease Pathophysiology, Climate-Linked Disruptions in Medication Availability and Treatment Strategies in movement disorders, and more.Provides the latest information on Effects of Climate Change in Movement Disorders researchOffers outstanding and original reviews on a range of Effects of Climate Change in Movement Disorders research topicsServes as an indispensable reference for researchers and students alike

Myoclonous, Volume 11 in the International Review of Movement Disorders series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Classification & Scales & Treatment, Electrophysiology, Diagnostic approach including differential diagnosis, Clinical Myclonus Syndromes, Cortical myclonus tremor, Spectrum of Progressive myclonus ataxia - Progressive myclonus epilepsy, Myclonus-dystonia, Functional myclonus, Genetic myclonus including genetic Metabolic disorders causing myclonus, Acquired myclonus (Toxic- and drug-induced, hypoxic-ischemic, Metabolic (non-genetic) and Inflammatory myclonus), Autoimmune and paraneoplastic myclonus, Neurodegenerative disorders and myclonus, and much more.Provides the latest information on Myoclonous researchOffers outstanding and original reviews on a range of Myoclonous research topicsServes as an indispensable reference for researchers and students alike

International Review of Movement Disorders series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.Provides the latest information on Recent Advances in Movement DisordersOffers outstanding and original reviews on a range of Recent Advances in Movement Disorders research topicsServes as an indispensable reference for researchers and students alike